{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "17509174",
  "DateCompleted": {
    "Year": "2007",
    "Month": "06",
    "Day": "22"
  },
  "DateRevised": {
    "Year": "2022",
    "Month": "03",
    "Day": "11"
  },
  "Article": {
    "ArticleDate": [],
    "Language": [
      "eng"
    ],
    "ELocationID": [],
    "Journal": {
      "ISSN": "0956-4624",
      "JournalIssue": {
        "Volume": "18",
        "Issue": "4",
        "PubDate": {
          "Year": "2007",
          "Month": "Apr"
        }
      },
      "Title": "International journal of STD & AIDS",
      "ISOAbbreviation": "Int J STD AIDS"
    },
    "ArticleTitle": "Association between active GB virus-C (hepatitis G) infection and HIV-1 disease in Uganda.",
    "Pagination": {
      "StartPage": "244",
      "EndPage": "249",
      "MedlinePgn": "244-9"
    },
    "Abstract": {
      "AbstractText": [
        "Although not linked to a disease, GB virus-C viraemia has been associated with an improved prognosis in HIV-1-co-infected individuals. Most studies have been conducted on men (men who have sex with men or injection drug users) infected with HIV-1 subtype B, whereas here we report on both male and female subjects from rural Uganda, predominantly infected via the heterosexual route with HIV-1 subtypes A and D. In a longitudinal study of 272 participants, 47 were GBV-C positive and 181 negative, as determined by reverse transcription-polymerase chain reaction, in both of two plasma samples taken a median of 5.0 years apart. The remainder either acquired (25) or cleared (19) infection. Multilevel regression analyses and Cox survival analyses revealed that participants chronically infected with GBV-C had a slower decline in CD4(+) T cells (P<0.001) and increased survival time (P=0.041) compared with GBV-C RNA-negative, HIV-positive adults. We show that the association between active GBV-C co-infection and improved survival of HIV-1-infected adults is not restricted to HIV subtype B, but is also observed in both males and females infected with HIV subtypes A and D."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Medical Research Council Research Unit on AIDS, c/o Uganda Virus Research Institute, PO Box 49, Entebbe, Uganda. dave.yirrell@nhs.net"
          }
        ],
        "LastName": "Yirrell",
        "ForeName": "D L",
        "Initials": "DL"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Wright",
        "ForeName": "E",
        "Initials": "E"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Shafer",
        "ForeName": "L A",
        "Initials": "LA"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Campbell",
        "ForeName": "E",
        "Initials": "E"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Van der Paal",
        "ForeName": "L",
        "Initials": "L"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Kaleebu",
        "ForeName": "P",
        "Initials": "P"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Grosskurth",
        "ForeName": "H",
        "Initials": "H"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Whitworth",
        "ForeName": "J A",
        "Initials": "JA"
      }
    ],
    "GrantList": [
      {
        "GrantID": "MC_U950080937",
        "Acronym": "MRC_",
        "Agency": "Medical Research Council",
        "Country": "United Kingdom"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Randomized Controlled Trial",
      "Research Support, Non-U.S. Gov't"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "England",
    "MedlineTA": "Int J STD AIDS",
    "NlmUniqueID": "9007917",
    "ISSNLinking": "0956-4624"
  },
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Adolescent"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Adult"
    },
    {
      "QualifierName": [],
      "DescriptorName": "CD4 Lymphocyte Count"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Child"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Disease Progression"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Female"
    },
    {
      "QualifierName": [
        "classification",
        "complications",
        "epidemiology"
      ],
      "DescriptorName": "Flaviviridae Infections"
    },
    {
      "QualifierName": [
        "classification",
        "isolation & purification"
      ],
      "DescriptorName": "GB virus C"
    },
    {
      "QualifierName": [
        "complications",
        "epidemiology",
        "physiopathology"
      ],
      "DescriptorName": "HIV Infections"
    },
    {
      "QualifierName": [
        "classification",
        "pathogenicity"
      ],
      "DescriptorName": "HIV-1"
    },
    {
      "QualifierName": [
        "classification",
        "complications",
        "epidemiology"
      ],
      "DescriptorName": "Hepatitis, Viral, Human"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Male"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Prognosis"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Rural Population"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Survival Analysis"
    },
    {
      "QualifierName": [
        "epidemiology"
      ],
      "DescriptorName": "Uganda"
    }
  ]
}